Literature DB >> 22133075

Anti-snake venom activities of extracts and fractions from callus cultures of Sapindus saponaria.

Marcos L da Silva1, Silvana Marcussi, Renata S Fernandes, Paulo S Pereira, Ana Helena Januário, Suzelei C França, Saulo L Da Silva, Andreimar M Soares, Miriam V Lourenço.   

Abstract

CONTEXT: Sapindus saponaria L. (Sapindaceae) bark, root, and fruits are used as sedatives and to treat gastric ulcer and also demonstrate diuretic and expectorant effects.
OBJECTIVE: The anti-snake venom properties of callus of S. saponaria are investigated here for the first time.
MATERIALS AND METHODS: In vitro cultivated callus of Sapindus saponaria were lyophilized, and the extracts were prepared with different solvents, before submitting to phytochemical studies and evaluation of the anti-ophidian activity. Crude extracts were fractionated by liquid-liquid partition and the fractions were monitored by thin layer chromatography (TLC). Subsequently, anti-ophidian activities were analyzed toward Bothrops jararacussu Lacerda (Viperidae), B. moojeni Hoge (Viperidae), B. alternates Duméril (Viperidea) and Crotalus durissus terrificus Lineu (Viperidae) venoms and isolated myotoxins and phospholipase A(2) (PLA(2)).
RESULTS: Fractions A1, A2 and the extract in MeOH:H(2)O (9:1) significantly inhibited the toxic and pharmacological activities induced by snake venoms and toxins, when compared to other extracts and fractions. The lethal, clotting, phospholipase, edema-inducing, hemorrhagic and myotoxic activities were partially inhibited by the different extracts and fractions. TLC profiles of the crude extracts (B and C) and fractions (A1 and A2) showed β-sitosterol and stigmasterol as their main compounds. Stigmasterol exhibited inhibitory effects on enzymatic and myotoxic activities of PLA(2). DISCUSSION AND
CONCLUSION: Sapindus saponaria extracts and fractions presented anti-ophidian activity and could be used as an adjuvant to serum therapy or for its supplementation, and in addition, as a rich source of potential inhibitors of enzymes involved in several pathophysiological human and animal diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133075     DOI: 10.3109/13880209.2011.608072

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

Review 1.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

2.  Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.

Authors:  C L S Guimarães; S H Andrião-Escarso; L S Moreira-Dill; B M A Carvalho; D P Marchi-Salvador; N A Santos-Filho; C A H Fernandes; M R M Fontes; J R Giglio; B Barraviera; J P Zuliani; C F C Fernandes; L A Calderón; R G Stábeli; F Albericio; S L da Silva; A M Soares
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

3.  Preliminary assessment of Hedychium coronarium essential oil on fibrinogenolytic and coagulant activity induced by Bothrops and Lachesis snake venoms.

Authors:  Cíntia A Sf Miranda; Maria G Cardoso; Mariana E Mansanares; Marcos S Gomes; Silvana Marcussi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-09-01

4.  A novel phospholipase A2 (D49) from the venom of the Crotalus oreganus abyssus (North American Grand canyon rattlesnake).

Authors:  W Martins; P A Baldasso; K M Honório; V G Maltarollo; R I M A Ribeiro; B M A Carvalho; A M Soares; L A Calderon; R G Stábeli; M A O Caballol; G Acosta; E Oliveira; S Marangoni; F Albericio; S L Da Silva
Journal:  Biomed Res Int       Date:  2014-02-24       Impact factor: 3.411

Review 5.  Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview from Traditional Use to Pharmacological Evidence.

Authors:  Juliana Félix-Silva; Arnóbio Antônio Silva-Junior; Silvana Maria Zucolotto; Matheus de Freitas Fernandes-Pedrosa
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-21       Impact factor: 2.629

Review 6.  Perspective on the Therapeutics of Anti-Snake Venom.

Authors:  Isabel Gómez-Betancur; Vedanjali Gogineni; Andrea Salazar-Ospina; Francisco León
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.